IntroductIon
Liver disease in children can present in many ways from the frequently encountered prolonged neonatal jaundice to the comparatively rare acute liver failure (ALF). Due to the supraregional structuring of UK hepatology services, paediatricians may have limited clinical exposure to these conditions. This article will focus on 'red flags' of liver disease, the initial investigations required and when to refer to a specialist liver centre.
Liver function tests (LFTs) are among the most frequently performed blood tests in children. They are often requested as part of an automated biochemistry panel, which results in incidental identification of abnormalities. While they may be valuable first-line investigations in the assessment of liver disease, they usually do not test the functional capacity of the liver. Indeed, these abnormalities are not necessarily specific for individual liver diseases, though some patterns may be observed.
Due to the liver's considerable functional reserves, liver disease often remains subclinical until relatively advanced. 1 2 Therefore, in addition to patients with symptoms or signs of liver disease (eg, jaundice and splenomegaly), evidence of liver (dys)function should be actively sought in certain groups of patients, for example, patients taking hepatotoxic medications such as methotrexate and patients with systemic conditions that may affect the liver such as ulcerative colitis with associated sclerosing cholangitis, or obesity and non-alcoholic fatty liver disease (NAFLD).
bAckground pAthophysIology
There are several key functions of the liver including synthetic, metabolic, production of bile and detoxification. Though variable, end-stage chronic liver disease tends to manifest in blood tests as coagulopathy and hypoalbuminaemia, while ALF results in coagulopathy, hypoglycaemia and hyperbilirubinaemia. The degree of abnormality of international normalised ratio (INR), albumin, pH, lactate, bilirubin and glucose correlates with the degree of hepatic dysfunction.
bilirubin
Bilirubin is the breakdown product of haem, 95% of which comes from red cell haemoglobin. It is produced as unconjugated bilirubin by the reticuloendothelial system and transported to hepatocytes, where it is converted to conjugated bilirubin before being exported into canaliculi. Therefore, an isolated rise in unconjugated bilirubin is usually not suggestive of hepatic disease, rather Gilbert syndrome or haemolysis.
liver enzymes
The enzymes that comprise the typical biochemical panel of LFT are not only expressed in the liver (see table 1 ). Hence, aspartate aminotransferase (AST) or alanine aminotransferase (ALT) elevation could be of muscle origin, and concomitant creatine kinase measurement is usually helpful to attribute the aminotransferase rise to muscle disease. 3 Mild elevations of ALT and AST occur in almost any liver condition. However, the degree of increase in aminotransferases does not
Best practice
give useful information about liver function or underlying diagnosis (see box 1).
Typically, alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) both rise in response to biliary injury (intrahepatic or extrahepatic), although ALP correlates with bone turnover in children. Therefore, GGT is used in preference as the main biliary enzyme during childhood.
liver 'function' tests
Hepatocytes synthesise the majority of all serum proteins, including albumin and clotting factors. Albumin is used as a medium-term marker of hepatic synthetic function. 4 INR and prothrombin time (PT) can be used as short-term markers of synthetic capacity, if haematological causes and vitamin K deficiency have been ruled out.
When should I Worry?
Given the insidious nature of chronic liver disease and high mortality of ALF, persisting clinical or biochemical abnormalities cannot be ignored. (See section on 'Which group of children can be reassured and followed-up locally?' for exceptions to this statement.) Evidence of impaired hepatic function (ie, prolonged clotting) is particularly worrying.
The most frequently encountered situations in general paediatrics that cannot be ignored are: prolonged conjugated jaundice in newborns, acutely elevated ALT or AST and NAFLD.
conjugated jaundice in newborns
A 3-week-old infant is referred to the paediatric unit due to jaundice. She is feeding well and thriving. Her perinatal period was uneventful. Clinical examination is normal other than mild icterus. Her urine is dark and stool are pale in colour. Prolonged jaundice is defined as visible jaundice at 14 days in term infants or 21 days in those born at less than 37 weeks. The most common cause for unconjugated hyperbilirubinaemia is breastfeeding-associated jaundice, which may be present in 25%-45% of breastfed neonates. 5 While prolonged, unconjugated jaundice cannot be ignored (eg, haemolysis should be excluded), it is usually not suggestive of liver disease.
There is a wide differential diagnosis for prolonged conjugated hyperbilirubinaemia. Prolonged conjugated hyperbilirubinaemia is defined as conjugated bilirubin comprising >20% of the total bilirubin or an absolute value of ≥25 μmol/L, irrespective of percentage fraction 6 7 (table 2) . The neonatal liver has a tendency to develop cholestasis in response to a variety of insults. Initial investigation should focus on: confirming conjugated hyperbilirubinaemia, looking for evidence of ALF or sepsis and then investigating the cause (table 2) . 7 Early discussion with a hepatology unit facilitates rapid investigation of time-critical diagnoses (eg, biliary atresia).
differential diagnoses of conjugated hyperbilirubinaemia
Biliary atresia is an important cause of neonatal cholestasis that will be familiar to all paediatricians. It accounts for 25% of all neonatal conjugated hyperbilirubinaemia presenting to a tertiary centre, and early treatment significantly improves outcomes. 8 Therefore, it is a time-critical diagnosis: the earlier an infant is referred and undergoes treatment, the more likely they are to survive with their native liver.
Biliary atresia typically presents with pale stools (not golden yellow or green; any other colour is compatible with diagnosis of biliary atresia), conjugated hyperbilirubinaemia, aminotransferases in the hundreds and an elevated GGT. Physical inspection of the stool to confirm the pigment by healthcare professionals is strongly recommended (figure 1).
The infant in this vignette has a conjugated hyperbilirubinaemia with pale stools, normal physical examination other than icterus. She has an elevated GGT. She is not in liver failure (and does not have vitamin K Best practice deficiency) given her normal INR. Pale stools suggest biliary atresia unless proven otherwise. The most likely diagnosis is biliary atresia, and she needs referral to a liver centre urgently for further investigation and management. Depending on the protocol of the liver centre for investigating infantile cholestasis, the nextline investigations would be: ancillary blood tests to exclude other causes (table 2) and an ultrasound scan, and liver biopsy, depending on the protocol of the liver centre for investigating infantile cholestasis. Once biliary atresia is excluded further differential diagnosis is usually a subject of extensive investigations. The differential diagnosis for conjugated jaundice can be narrowed down by clinical assessment and GGT. In unwell neonates, consider sepsis, or ALF due to herpes simplex virus (with high transaminases) or neonatal haemochromatosis (low transaminases). In well neonates, such as this case, consider biliary atresia or alpha-1-antityrpsin deficiency if the GGT is high. Whereas, some types of progressive familial intrahepatic cholestasis present in a similar manner to biliary atresia but with a paradoxically low GGT.
Acute hepatic dysfunction, without liver failure
A 13-year-old girl presents with jaundice after generally feeling unwell for 1 month. This teenager has presented with a short history of new-onset conjugated jaundice associated with elevated aminotransferases. She is not in ALF as her INR normalised following vitamin K administration, suggesting vitamin K deficiency, which may be due to inadequate bile acid delivery to the gut. This is an acute-on-chronic presentation, as evidence by Best practice low albumin, and thrombocytopaenia due to hypersplenism from portal hypertension.
This presentation is not a life-threatening emergency (given the normal INR) but does require investigation and discussion with a liver centre urgently. The main differential diagnosis is between autoimmune hepatitis (AIH) and Wilson disease (WD). Initial investigations are discussed below but should include immunoglobulins, autoantibodies, caeruloplasmin and a viral hepatitis screen (see table 3 ). There is potential for this teenager to deteriorate and therefore needs follow-up locally until care is taken over by a hepatology unit.
Autoimmune hepatitis
AIH is a rare condition of hepatic inflammation associated with circulating non-organ specific autoantibodies. 9 It demonstrates a good response to immunosuppression, which greatly improves the clinical outcome for affected children. The two most discriminatory laboratory investigations are immunoglobulin G titre and high-titre autoantibodies. Early referral to a tertiary liver centre, where a liver biopsy may be performed to confirm the diagnosis, allows corticosteroids to be initiated and reduce progressive hepatic injury.
Wilson disease
WD is an autosomal recessive disorder of copper accumulation that causes acute or chronic liver disease, basal ganglia damage and Coombs' negative haemolysis. Ruling out WD is challenging, though patients with WD may have higher bilirubin, ALT/AST in low hundreds and low ALP. Caeruloplasmin is low in the majority of affected patients but is not 100% sensitive. Additional tests that help establish diagnosis of WD include urine copper, liver copper estimation and mutational analysis (for ATP7B mutation). Although rare, WD is an important diagnosis that should not be forgotten as it is treatable and neurological damage is permanent, even if patients undergo liver transplant.
An incidental finding of deranged lFts
A 15-year-old girl is seen by the paediatric surgical team with vague abdominal pain. Body mass index (BMI) 32.9 kg/m 2 , BMI z-score +2.29 and waist circumference 99th centile. This 15-year-old girl has had incidental abnormalities identified in her LFTs, and the most likely diagnosis is NAFLD.
A careful history and examination should be undertaken. An ultrasound demonstrating increased hepatic echogenicity (suggestive of fat infiltration), a negative panel of secondary investigations (see table 4 ) and no history of alcohol intake would suggest a diagnosis of NAFLD in the context of an obese child. If in doubt, discuss with a tertiary liver centre. Diagnosis can only formally be made by liver biopsy, which is also useful for staging disease.
NAFLD is the most common liver disease in children; 40% of obese children are affected. 10 NAFLD describes a spectrum from isolated steatosis through non-alcoholic steatohepatitis (NASH) to fibrosis and cirrhosis. 11 The condition is intimately related to obesity, insulin resistance and the metabolic syndrome.
NAFLD cannot be ignored for three main reasons. First, it may mask another liver disease with specific treatment (eg, WD) masquerading as NAFLD. Second, it highlights that affected children are at high risk of developing type 2 diabetes and cardiovascular disease in adult life. Finally, it is not a benign condition: up to 9% of children with only 'mildly' abnormal LFT can have stage 3/4 fibrosis on biopsy. 12 There is no correlation between ALT and fibrosis, which is the best marker of long-term outcome in adults. 13 This statement is true for many chronic liver diseases: normal AST and ALT give little information Best practice about progression of the condition. The treatment of paediatric NAFLD is outlined in box 2.
When should I be reAlly WorrIed?
Any evidence of acutely impaired hepatic function is worrying and should be treated as a potentially life-threatening emergency (see box 4).
Acute liver failure
A 5-year-old girl presents to accident and emergency with sudden onset jaundice and malaise. This girl has presented with ALF, as identified by coagulopathy (INR >2.0) that is unresponsive to vitamin K associated with biochemical evidence of hepatocellular injury. Note the difference in this vignette of the persistently prolonged INR after intravenous vitamin K compared with the 13-year-old girl discussed earlier in this article. There is no indication for fresh frozen plasma unless there is active bleeding.
An INR >1.5 with evidence of encephalopathy would also be classed as ALF. This is a medical emergency; any child with an abnormal INR and suspected ALF should be referred to a hepatology transplant unit within hours. The differential diagnosis of ALF includes: infectious causes, metabolic causes, drugs and toxins (paracetamol overdose), rarities and indeterminate (non-A-E hepatitis). Vital initial investigations are listed in table 3 17 . If there is no history of drug or toxin exposure, then the most likely causes are viral or metabolic. ALF in infancy is more frequently due to metabolic disorders, including galactosaemia and tyrosinaemia. However, at 5 years old, WD may present acutely with Coombs' negative haemolysis, ALF and renal impairment.
life-threatening emergencies in AlF
An awareness of prognostic factors in ALF is necessary to guide management. Early identification of children who will not survive with their native liver allows more rapid listing for transplant. In non-paracetamol ALF, an INR >4 alone would be a poor prognostic marker. In paracetamol-induced ALF, acidosis, renal impairment, raised lactate and encephalopathy are more important. There is no correlation between ALT and outcome in all cases of ALF.
Box 2 Management of non-alcoholic fatty liver disease (NAFLD)
Children with NAFLD should be managed in accordance with guidance from the Royal College of Paediatrics and Child Health Obesity Services for Children and Adolescents group.
14 There are no uniformly accepted pharmacological therapies recommended for paediatric NAFLD other than weight loss and exercise. Some of the situations for when a biopsy may be indicated in NAFLD are listed in box 3 but discuss cases with tertiary hepatology services for any child with persisting increased ultrasound echogenicity, elevated transaminases or splenomegaly. 
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WhIch pAtIent group WIth AbnormAl lFts cAn be reAssured And mAnAged locAlly? Liver disease may progress despite an absence of signs or biochemical abnormalities. Therefore, no LFT abnormalities can be ignored.
However, abnormal LFTs are less worrying if there is an obvious systemic cause, the LFT returns to normal once the child is well, there is no evidence of impaired liver function and a detailed examination shows no concerning features. For example, a 9-year-old child with clinical features of infectious mononucleosis, an isolated raised ALT of 80 IU/L, which returns to the normal range within 2 weeks, and normal clotting, does not need further investigation. The ALT must be repeated after the acute episode, and if it remains above the upper limit of normal, then this should be investigated. If the child had a palpable liver during the acute episode (which could be due to acute EBV), then a follow-up ultrasound would be required.
Chronic liver disease is silent, and early diagnosis improves outcomes; therefore, abnormalities should be followed-up with an ultrasound and bloods.
What are the key examination findings and investigations that I should perform?
Clinical signs of liver disease appear late and are usually non-specific. Signs of chronic liver disease include leukonychia, digital clubbing, spider naevi, splenomegaly and cachexia. Acute or chronic liver disease may cause ascites or encephalopathy. The presence of an asterixis ('liver flap') is very sensitive for the presence of encephalopathy and must be tested.
WD may present initially with neurological features, and the basal ganglia must be formally examined for bradykinesia or dyskinesia. NAFLD may be associated with acanthodians nigricans, suggestive of significant insulin resistance.
When discussing patients with a tertiary liver centre, it can feel like an almost endless list of investigations are recommended. However, there is no other way to identify the underlying cause, and this is necessary to determine the urgency of specialist investigations and treatment.
The single most important investigation is clotting, particularly PT (or INR). If prolonged, intravenous vitamin K should be given, then the clotting should be repeated. If the INR remains prolonged, this is suggestive of impaired hepatic synthetic capacity and needs urgent referral.
The core investigations to be performed are determined by the age and clinical presentation of the child. For example, neonatal ALF would require herpes simplex virus PCR urgently, but it would be a rare cause for older children. Table 4 gives an initial set of investigations to perform in the setting of unexplained, abnormal LFTs in a child (>4 years) who does not have liver failure. If in doubt, discuss with a tertiary liver centre.
